Last reviewed · How we verify
NCT06891924
A Clinical Study on Pre-operative Intervention With Products During Aesthetic Medicine
NA trial testing 14-day daily pre-operative application of the formulations containing MLYAAT-1002® before Fotona4D treatment in Skin Aging in 33 participants. Not yet recruiting.
1 June 2025
Quick facts
| Lead sponsor | Botanee Group Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 33 |
| Start date | 25 March 2025 |
| Primary completion | 1 June 2025 |
| Estimated completion | 1 June 2025 |
Drugs / interventions tested
- 14-day daily pre-operative application of the formulations containing MLYAAT-1002® before Fotona4D treatment
- 14-day daily pre-operative application of the formulations without MLYAAT-1002® before Fotona4D treatment
Conditions studied
- Skin Aging — all drugs for Skin Aging →
- Skin Condition — all drugs for Skin Condition →
- Skin Manifestations — all drugs for Skin Manifestations →
Sponsor
Botanee Group Co., Ltd.
Who can join
Adults 35 to 60, female only, with Skin Aging or Skin Condition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical trial aims to evaluate whether a 14-day pre-operative application of the test product (containing MLYAAT-1002®, a proprietary anti-aging complex) can mitigate skin discomfort during Fotona 4D laser therapy (Frac3 and Piano modes) by comparing clinical evaluation, skin attributes measurement and subject self-assessment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06891924
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Skin Aging
Currently open trials in the same condition.
- NCT07381218 — Focused Ultrasound Treatment for Facial Skin Laxity · NA · active not recruiting
- NCT06900660 — Evaluation of the Skin-Beautifying Effects of Collagen Drinks · NA · active not recruiting
- NCT06804772 — A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the · NA · active not recruiting
- NCT06816069 — Study on Safety and Efficacy of Monopolar Radio Frequency Device for Facial Skin Tightening · NA · active not recruiting
- NCT06727292 — Biometrical Evaluation of the Efficacy of a Food Supplement Versus Placebo · NA · recruiting
Other Botanee Group Co., Ltd. trials
Trials by the same sponsor.
- NCT06188338 — A 56-day Clinical Study on Facial Skin Rejuvenation · NA · completed
- NCT06140628 — A 28-day Clinical Study on Facial Skin Rejuvenation · NA · completed
- NCT05908903 — A Clinical Study on the Improvement of Sleep Quality, Skin Condition and Life Status After Taking Sleep Aid Drinks · NA · completed
- NCT06274450 — A Clinical Study on the Improvement of Skin and Living Conditions After Drinking Rosa Roxburghii and Pomegranate Drinks · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06891924 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Botanee Group Co., Ltd.
- Last refreshed: 1 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06891924.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing